* GSK scrapping doctor payments for speaking engagements
* Ending sales reps' targets globally following U.S. move
* Comes amid criticism of aggressive industry sales tactics
* Move may pressure other drug companies to follow suit
By Ben Hirschler
LONDON, Dec 17 (Reuters) - GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff - a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit.
Britain's biggest drugmaker also said on Tuesday it would stop payments to healthcare professionals for attending medical conferences as it tries to persuade critics it is addressing conflicts of interest that could put commercial interests ahead of the best outcome for patients. read more
Britain's biggest drugmaker also said on Tuesday it would stop payments to healthcare professionals for attending medical conferences as it tries to persuade critics it is addressing conflicts of interest that could put commercial interests ahead of the best outcome for patients. read more
No comments:
Post a Comment